Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Yangtze River Delta advances high-quality integrated development

Published

on

yangtze-river-delta-advances-high-quality-integrated-development

BEIJING, Dec. 1, 2023 /PRNewswire/ — A report from People’s Daily: The Yangtze River Delta is one of the most economically vibrant, open and innovative regions in China. It encompasses four major economic engines – Shanghai, Jiangsu, Zhejiang and Anhui.

Shanghai serves as a frontier of openness and a prime innovation hub. Jiangsu province features strong real economy. Zhejiang province boasts a developed private economy. Anhui province possesses a rather comprehensive industrial system and rich scientific and technological resources…

On Nov. 5, 2018, Chinese President Xi Jinping announced at the opening ceremony of the first China International Import Expo that China would support integrated development of the Yangtze River Delta region, and make it a national strategy.

Over the past five years, the region’s night light development index jumped 57.24 percent, and the number of cities with a GDP of over 1 trillion yuan ($141.29 billion) increased to eight, or around 1/3 of the total in China. The integrated development strategy has brought tremendous changes to the Yangtze River Delta, writing a new chapter on Chinese modernization.

“In the past, when we encountered technical difficulties, we had to find solutions and resources by ourselves. Now we can directly post requests on the platform,” said Yang Weizhong, executive chairman of Shanghai Different Advanced Material Co., Ltd. (Shanghai Different), referring to an open competition platform for selecting the best candidates to undertake research projects launched by Shanghai’s Pudong New Area earlier this year.

According to him, developing high-performance hybrid fiber materials had been a headache bothering the company for years. Immediately following the launch of the platform, Shanghai Different posted its technical requests, which were soon picked up and solved by Jiangsu Gem Advanced Fiber Materials.

“Integrated development truly brings innovation resources to one focal point, opening up new possibilities,” Yang noted.

Innovation possesses the core position in China’s modernization drive. In recent years, the synergetic innovation index in the Yangtze River Delta region has been growing at 9.47 percent annually on average, and the region has shared 23 major scientific research facilities and more than 40,000 large scientific instruments. High-caliber technological supplies are effectively bolstering the high-quality economic development of the region.

On May 28 this year, C919, China’s self-developed large passenger aircraft, completed its first commercial flight, which was a testimony to the manufacturing muscle of the Yangtze River Delta. About 10 percent of the aircraft’s parts, 50 percent of its aluminum materials, and 50 percent of composite structural components were manufactured in Zhenjiang, Jiangsu province.

It marked a close collaboration and integration of industrial chain resources among Yangtze River Delta cities, including Shanghai, Hefei, Hangzhou, Suzhou and Zhenjiang, which realized the dream of the Chinese people to make a large passenger jet of their own.

Under the promotion by Commercial Aircraft Corporation of China, C919’s main manufacturer, around 1,000 enterprises in the nine cities and districts along the G60 Science and Innovation Corridor have been incorporated into the aircraft manufacturing chain.

In Changzhou, a series of innovative industrial clusters have sprouted up around the new energy industry chain, with production value already surpassing 500 billion yuan.

In Jiaxing, the Yangtze Delta Region Institute of Tsinghua University, Zhejiang and the Zhejiang Institute of Advanced Technology under the Chinese Academy of Sciences are thriving; top-tier scientific innovation platforms – China Nanhu Academy of Electronics and Information Technology, Nanhu Laboratory, and Institute of Flexible Electronics Technology of Tsinghua University, Zhejiang – have also been launched.

In Hefei, Chinese new energy vehicle giant BYD has built a new manufacturing base, while establishing supporting facilities for key components like power batteries, battery materials, high-voltage devices and wire harnesses in Bengbu, Chuzhou and Fuyang, to form a comprehensive industry chain.

“These epitomize the modernized industrial landscape in the Yangtze River Delta, the unique strengths bred by integrated development,” remarked BYD chairman and president Wang Chuanfu.

The ever-strengthening innovation and industrial chains come from the continuous unleashing of the talent chain. As the Yangtze River Delta’s primary attraction for talents and highland for innovation, Shanghai welcomes both domestic and foreign talents, while also encouraging various talents to fully realize their potential in the region.

Jiangsu, Zhejiang, and Anhui provinces have established incubators and empowerment centers in Shanghai to further tap the metropolitan’s advantages in talent attraction and innovation resources.

“Previously, for foreigners in China to work in the securities industry, they had to ‘follow local customs’ and sit China’s securities qualification exam – a tall task halting many international finance talents,” said Park Pu, Chairman of J.P. Morgan Securities (China).

“Now Pudong has set up an international finance qualification accreditation catalog system, creating favorable conditions to draw global experts,” Pu added.

Integrated development is not a simple equation of combining strengths, but rather realizing complementary advantages and building synergy to form new advantages of high-quality development.

As the strategy of integrated development moves ahead, the four major economic engines of the Yangtze River Delta will work together even more closely to propel high-quality development.

 

View original content:https://www.prnewswire.co.uk/news-releases/yangtze-river-delta-advances-high-quality-integrated-development-302003688.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending